Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$30,839,978
+$2,618,055 QoQ
Shares Held
871,432
-14.5% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#71
of 494 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. ROIV ranks #9 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in ROIV
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,839,978 | 871,432 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $28,221,923 | 1,018,842 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $748,411 | 34,489 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $837,112 | 55,328 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,334,120 | 118,378 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,194,434 | 118,378 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,400,411 | 118,378 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,366,082 | 118,378 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,251,255 | 118,378 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,247,704 | 118,378 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,543,815 | 849,850 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,926,248 | 849,850 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,125,936 | 111,700 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $813,645 | 110,250 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $880,897 | 110,250 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $114,632 | 35,600 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||